Intracellular Cobalamin Defect in Early Infancy: A Cause of Hypotonia and Cytopenias
Open Access
- 1 January 2026
- journal article
- Published by Wiley in Case Reports in Medicine
- Vol. 2026 (1) , 9545724
Abstract
Intracellular cobalamin metabolism defects (ICMDs) are rare but inherited disorders that disrupt the conversion of cobalamin into its active cofactors, methylcobalamin and adenosylcobalamin. We report a 40‐day‐old female infant with progressive hypotonia, poor feeding, hydrocephalus, and pancytopenia, whose metabolic profile demonstrated severe hyperhomocysteinemia, elevated urinary methylmalonic acid, and low methionine despite normal serum vitamin B12. Bone marrow evaluation revealed profound hypercellularity with megaloblastic changes and hypersegmented neutrophils. These findings suggested an intracellular cobalamin defect, most consistent with the cblC subtype. Molecular analysis confirmed a homozygous frameshift mutation in the MMACHC gene, establishing the diagnosis of methylmalonic aciduria and homocystinuria, cblC type. Treatment with hydroxocobalamin, betaine, and folinic acid led to stabilization of hematologic parameters and significant clinical and biochemical improvement; however, it is important to recognize that therapy is not curative, and long‐term neurodevelopmental outcomes may remain guarded, especially in early‐onset cases.Keywords
This publication has 11 references indexed in Scilit:
- First pathogenic non-coding variant in MMACHC: a functional deletion in the 5′-UTR associated with cobalamin C deficiencyMolecular Biology Reports, 2025
- Effects of Vitamin B12 Deficiency on Hemogram Parameters and Its Relationship With Thyroid Hormones in InfancyJournal of Paediatrics and Child Health, 2025
- Clinical and electroencephalogram characteristics of methylmalonic acidemia with MMACHC and MUT gene mutationsBMC Pediatrics, 2024
- The MMACHC variant c.158T>C: Mild clinical and biochemical phenotypes and marked hydroxocobalamin response in cblC patientsMolecular Genetics and Metabolism, 2024
- Late-onset methylmalonic acidemia and homocysteinemia (cblC disease): systematic reviewOrphanet Journal of Rare Diseases, 2024
- Versatile enzymology and heterogeneous phenotypes in cobalamin complementation type C diseaseiScience, 2022
- The clinical presentation of cobalamin‐related disorders: From acquired deficiencies to inborn errors of absorption and intracellular pathwaysJournal of Inherited Metabolic Disease, 2018
- Evaluation of the efficacy of amplitude-integrated electroencephalography in the screening of newborns with metabolic disorder admitted to the NICUBMC Medical Imaging, 2018
- Atypical hemolytic uremic syndrome induced by CblC subtype of methylmalonic academiaMedicine, 2017
- Guidelines for diagnosis and management of the cobalamin‐related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiencyJournal of Inherited Metabolic Disease, 2016